Asia Pacific Drug Formulation & Bioavailability Congress

September 05-07, 2016 Beijing, China

Theme: Advanced Drug Formulation perspectives for Comprehensive Bioavailability

DoubleTree by Hilton Beijing168 Guang An Men Wai Avenue, Xi Cheng DistrictBeijing, China

Conference Dates: September,05-07, 2016

Conference Venue

Drug formulation-2016 welcomes Students, Pharmaceutical companies / industries, leading universities and research institutions, presenters, and exhibitors from all over the world to Beijing, China. We are delighted to invite you all to attend and register for the “Asia Pacific Drug Formulation & Bioavailability Congress” (Drug formulation -2016) which is going to be held during September 05-07,2016 at Beijing, China. We invite you to join us at the Drug Formulation 2016, where you will be sure to have a meaningful experience with scholars from around the world. All members of the Drug Formulation 2016 organizing committee look forward to meeting you in Beijing, China.

OMICS International Organizes 300+ Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 400+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

About Conference

Why China?China is currently the third largest pharmaceutical market in the world, posting $67 billion in revenue in 2011. With an anticipated compound growth rate of 24% between 2010 and 2020, China is expected to be the second largest market by 2015. Currently, there are about 1,400 drug companies in China that are, collectively, able to produce more than 60 dosage forms and about 5,000 different types of medicines. The current Chinese market value of the dosage form medicines is worth about $50 B, accounting for about 5.7% of the global market value. Internally, aiming to transform the Chinese pharmaceutical industry, the Chinese government is encouraging the Chinese drug companies to upgrade their manufacturing facility and improve their product quality. It is therefore believed that the Chinese dosage form drug market will continue to grow in a fast pace. It is expected to likely experience a CAGR of about 25% in the next five years. Its

market value could reach more than $158bn in 2016, and expand to 2023.

Market Analysis

The global generics sector reached $269.8 billion in 2012. This sector is expected to reach $300.9 billion in 2013 and $518.5 billion in 2018, with a compound annual growth rate (CAGR) of 11.5%.

An overview of the global market for generic drug including coverage of therapeutic

Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.The North American market is estimated to reach nearly $73 billion in 2011 and is expected to increase at a 7.9% compound annual growth rate to reach nearly $107 billion in 2016.

The United States is currently spending almost $250 billion a year for prescription drugs. If drugs were sold in a competitive market, without government-imposed patent monopolies, this might achieve savings up to $200 billion a year.

Market Analysis

Conference Highlights

Preformulation & Formulation Biopharmaceutics Classification System

Drug Formulation ProceduresBioavailability Studies & Factors Affecting Bioavailability

Novel Drug Delivery System & Stability Studies

Nutrient & Advances In Bioavailability

Drug Product Manufacturing Medicinal Chemistry & Traditional Medicine

Analytical Method Development

Clinical Studies & Contract Research Organizations

Special Issues [OMICS Journals]

All accepted abstracts will be published in respective OMICS International Journals.

Journal of Pharmaceutics & Drug Delivery Research

Drug Designing Journal of Developing Drugs Journal of Bioequivalence & Bioavailability Abstracts will be provided with Digital

Object Identifier by

Special Benefits  All accepted abstracts will be published in the

respective Journal Abstracts will receive a (DOI) provided by CrossRef Special privileges on group registrations Opportunity to organize Workshop/Symposia Global Exposure to your Research Best poster competition Young researcher competitions

 Organising Committee members:

Abdulmohsen H. Alrohaimi, Dean, School of Pharmacy, University in Shaqraa, Saudi Arabia.

Peng Li, Scientist in Medicine, University of California, Canada Weiguo Dai, Scientific Director for Johnson &Johnson , USA Sinerik Ayrapetyan, Professor in UNESCO, Armenia Duc P. Do, Associate Professor at Chicago State University

College of Pharmacy, USA Ibrahim Al-Khars, President at AlAhsa Pharmacy Club, Saudi

Pharmaceutical Society, Saudi Arabia M. Fawzi Mahomoodally, Professor at University of Mauritius,

Mauritius.

Exhibition

Why to attend Drug Formulation 2016?

Best platform to develop new partnership & collaborations. Best location to speed up your route into every territory in the

World. 89% our conference attendees are the Key contact in their

labs purchasing decisions. Our exhibitor booths were visited 4-5 times by 80% of the

attendees during the conference. Past exhibitor’s feedback reveals ample of enquiries

perceived from the conference attendees. Network development with both Academia and Business.

Join Our Mailing List Suggest A Speaker Suggestions Invite Proposals

Be a member and support us